ConCallIQ
Go Pro
CIPLA Healthcare 25 Jul 2025

Cipla Ltd — Q1 FY26

Cipla reported Q1 FY26 revenue of INR 6,957 crore (+4% YoY) with EBITDA margin of 25.6% (flat YoY) and PAT of INR 1,298 crore (+10.2% YoY).

neutral medium
Compare with...
Revenue ₹6,957 Cr +4%
EBITDA
PAT ₹1,298 Cr +10.2%
EBITDA Margin 25.6%
Duration
Read Time 1 min read

✓ Verified against BSE filing

Delivery score0%
Due this quarter1
Delivered0
Missed1

Indian management teams deliver on roughly 12% of specific earnings-call promises. A low score does not indicate dishonesty — it reflects how aspirational forward guidance typically is.

Q4 FY25

U.S. revenue run rate of ~$220 million for Q1 FY26

Management indicated U.S. revenue for the next quarter is expected to be around $220 million, factoring in Revlimid compression.

Missed

Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.

heuristic_v1